These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 32150664)

  • 21. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
    Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
    [No Abstract]   [Full Text] [Related]  

  • 22. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
    World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index.
    Nartey YA; Awuku YA; Agyei-Nkansah A; Duah A; Bampoh SA; Ayawin J; Asibey SO; Björkström NK; Ye W; Afihene MY; Roberts LR; Plymoth A
    BMC Gastroenterol; 2020 Dec; 20(1):428. PubMed ID: 33357229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reappraisal of the diagnostic value of alpha-fetoprotein for surveillance of HBV-related hepatocellular carcinoma in the era of antiviral therapy.
    Qian X; Liu S; Long H; Zhang S; Yan X; Yao M; Zhou J; Gong J; Wang J; Wen X; Zhou T; Zhai X; Xu Q; Zhang T; Chen X; Hu G; Wang J; Gao Z; Nan Y; Chen J; Hu B; Zhao J; Lu F
    J Viral Hepat; 2021 Jan; 28(1):20-29. PubMed ID: 32852885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
    El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
    Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection--results from a clinic-based longitudinal cohort.
    Hann HW; Fu X; Myers RE; Hann RS; Wan S; Kim SH; Au N; Xing J; Yang H
    Eur J Cancer; 2012 Oct; 48(15):2319-27. PubMed ID: 22436980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma.
    Liu K; Ding Y; Wang Y; Zhao Q; Yan L; Xie J; Liu Y; Xie Q; Cai W; Bao S; Wang H
    Clin Exp Med; 2023 Jun; 23(2):397-409. PubMed ID: 35347503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
    Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
    Xiao GQ; Yang JY; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Serum DNASE1L3 in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Ouyang B; Xie QQ; Huang W; Wang L; Tang S; Fu J
    Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Non-Coding RNA IGF2AS in Serum may be a Biomarker for Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Qi J; Li J; Sun J; Li C
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.
    Tajiri H; Takano T; Tanaka H; Ushijima K; Inui A; Miyoshi Y; Ozono K; Abukawa D; Endo T; Brooks S; Tanaka Y
    Cancer Med; 2016 Nov; 5(11):3102-3110. PubMed ID: 27748053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.